1 / 10

2003-2004 Review of Antiparkinson drugs

2003-2004 Review of Antiparkinson drugs. 20 December 2019 2:05 PM. Benztropine. Anticholinergic Antiparkinson Muscarinic receptor antagonist. Bromocriptine. Antiparkinson Dopamine (D 2 ) agonist Inhibits prolactin release. Carbidopa. Antiparkinson Peripheral dopa decarboxylase inhibitor.

amaggie
Download Presentation

2003-2004 Review of Antiparkinson drugs

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. 2003-2004Review ofAntiparkinson drugs 20 December 20192:05 PM

  2. Benztropine • AnticholinergicAntiparkinson • Muscarinic receptor antagonist

  3. Bromocriptine • Antiparkinson • Dopamine (D2) agonistInhibits prolactin release

  4. Carbidopa • Antiparkinson • Peripheral dopa decarboxylase inhibitor

  5. Deprenyl/selegiline • Antiparkinson • Monoamine oxidase B inhibitor(MAO-I)Potentiates effects of L-Dopa

  6. Entacapone • Antiparkinson • Peripheral catechol-o-methyltransferase inhibitor

  7. Levodopa • Antiparkinson • Dopamine precursor

  8. Pramipexole • Antiparkinson • Dopamine agonist (non-ergot)

  9. Ropinirole • Antiparkinson • Dopamine agonist (non-ergot)

  10. Trihexyphenidyl • Antiparkinson • Antimuscarinic

More Related